5-HT1A-mediated lower lip retraction: Effects of 5-HT1A agonists and antagonists

[1]  C. Dourish,et al.  Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat. , 1992, European journal of pharmacology.

[2]  J. Barrett,et al.  Modification of the discriminative stimulus effects of 8-OH-DPAT, buspirone and the beta-adrenoreceptor antagonist pindolol after chronic administration of the 5-HT(1A) agonist 8-OH-DPAT in the pigeon. , 1991, Behavioural pharmacology.

[3]  M. Durcan,et al.  Is NAN-190 an effective antagonist of the hypothermia and hyperglycemia induced by the 5-HT1A receptor agonist, 8-OH-DPAT? , 1991, European journal of pharmacology.

[4]  R. Glennon,et al.  NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors , 1990, Brain Research.

[5]  H. Berendsen,et al.  Antagonism of 8-OH-DPAT-induced behaviour in rats. , 1990, European journal of pharmacology.

[6]  M. Leathley,et al.  In vivo interactions of NAN-190, a putative selective 5-HT1A antagonist, with ipsapirone , 1989, Pharmacology Biochemistry and Behavior.

[7]  H. Berendsen,et al.  Selective activation of 5HT1A receptors induces lower lip retraction in the rat , 1989, Pharmacology Biochemistry and Behavior.

[8]  R. Glennon,et al.  NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). , 1988, European journal of pharmacology.

[9]  S. Hjorth,et al.  Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? , 1986, European journal of pharmacology.

[10]  J. Fozard,et al.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. , 1984, European journal of pharmacology.